Right time to invest? – Copart Inc. (CPRT), Eastman Chemical Company (EMN)

You should consider shares of Copart Inc. (NASDAQ:CPRT) and Eastman Chemical Company (NYSE:EMN) if you are looking for a great stocks to invest in. Starting with the CPRT shares, which traded at $87.28 at the close of the recent session, dropping -0.77%. On Tuesday, the company’s shares shed -$0.68 from its value which represented in intraday trading. The stock is now 70.54% higher in year-to-date (YTD) trading. CPRT’s intraday high was $87.89 while its lowest price touched $86.61. The stock’s 52-week high price is $92.41, which means the current price is at -5.55%. In terms of trading activity, the daily trading volume fell to 1390729 against 200-day average trading volume of 1,436,049 shares.

What are analyst forecasts for Copart Inc. (NASDAQ:CPRT)?

At a consensus rating of 3.50, CPRT is trending as a streaking Moderate Buy, as it has been the case a month ago when 8 analysts called it a Moderate Buy. Two months ago, 8 analysts recommended, on average, that CPRT stock is a Hold. The Services company’s shares’ overall bearish trend saw it close higher on Tuesday compared to its opening price of $87.55 on the day.

Forecasts for Copart Inc. (NASDAQ:CPRT) give the stock a fair value for the growth of 9.08% from its last price. The 12-month price forecast for the stock by analysts puts the stock’s mean price target at $96.00, which means the price per share could rise by nearly $8.72. The price range target is between a low of $79.00 and a high of $102.00. The stock would need to gain by about $14.43 to hit the estimated high or 0.51% from its 12-month low.

The consensus among 11 analysts is that it is a good time for one to Overweight in the Copart Inc. 4 analysts rate CPRT as a Buy, with 1 of 11 analysts rate it as a Sell. 1 have valued the stock as Overweight and 5 have recommended that investors Hold.

Copart Inc. (NASDAQ:CPRT) Upgrades and Downgrades

In terms of rating changes, Guggenheim on October 18, 2019, Upgrade Copart Inc. (CPRT) at Buy. They believe the stock could reach $93 in the near term. Analysts at Guggenheim have assigned a Neutral rating for the stock in their research note on May 17, 2019. Moreover, JP Morgan analysts issued a rating of Underweight for the stock on September 21, 2018, giving it a price target of $47 for the next 12 months. On September 20, 2018, the stock earned a Buy rating due to an analyst call from Gabelli & Co, while analysts from Stephens on May 18, 2018 suggested that the stock is Equal-Weight.

Eastman Chemical Company (NYSE:EMN) adds -$2.86 on Tuesday

The EMN stock has risen 3.30% year-to-date and is currently trading at $75.52, which is -12.37% below its 52-week high. The company shares lost -3.65% on the day and have risen nearly 23.36% off a low hit. At current levels, Eastman Chemical Company has a valuation of about $9.44B. As of 12/03/19, this stock has fallen -4.60% during the week and closed at $78.38 in the previous session. However, recent Eastman Chemical Company stock performance shows that EMN shares are -4.37% down over the last month, and 16.04% up for the last three months.

Earnings per share (EPS) estimates for the current quarter are $1.6, with the trailing 12-month share earnings at $5.35. The ratio is expected to be down by -13.30% for the current year 2019 and 11.00% for next year. Over the next 5-year period, earnings per share will be 4.26%. But will the EMN stock surprise in the current quarter results, where the $1.94 actual EPS reported on 9/29/2019 surprised by -2.00% or was lower by -$0.04 from the estimated $1.98.

Sales Growth to climb 2.30% for the year

How well will Eastman Chemical Company perform as a business over the current quarter, year and next 5-year period? Compared to the year-ago quarter, analysts forecast the company to bring in between $2.11B and $2.3B in current quarter sales. The consensus estimated for the current quarter is $2.22B from sales. Forecasts for this fiscal year are between $9.17B and $9.43B and the consensus estimate for sales is at $9.29B. EMN has its next quarter sales estimates at between $2.42B and $2.42B, with the quarter-over-quarter growth estimates at -6.30% and the annual growth forecast for the year at 2.30%.

Who owns shares in Eastman Chemical Company (EMN)?

Let’s briefly focus on the share ownership of the Eastman Chemical Company (NYSE:EMN) stock, where we find that 85.56% of shares are held by institutions. Vanguard Group, Inc. (The) tops the list of institutional owners as it is holding 14.61 million shares or 10.74% of shares outstanding. Blackrock Inc. and State Street Corporation held 9.8 million and 6.5 million representing 7.21% and 4.78% respectively at the close of the last trading session. As of Sep 29, 2019, JP Morgan Chase & Company accounted for 6.35 million shares at over 468.72 million. This represented 4.67% of shares outstanding. Lsv Asset Management held 5.47 million shares at over 403.51 million representing 4.02% of shares outstanding.

EMN Insider Activity

On 12/07/2018, Director by the name Raisbeck David Wayne bought 13500.0 shares worth $988300.0 at the price of $73.21 per share. Filings also show that Lich Brad A sold a total of 9248.0 shares on 2/28/2019 valued at $764700.0. Since the last insider activity, the company’s share price has dropped -5.21%.